Influenza A virus H7N9 vaccine - Hualan Biological Bacterin
Latest Information Update: 28 Feb 2019
Price :
$50 *
At a glance
- Originator Hualan Biological Bacterin
- Class Influenza A vaccines; Influenza A virus H7N9 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H7N9 subtype
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for phase-I development in Influenza-A virus H7N9 subtype(Prevention) in China (IM, Injection)
- 23 Mar 2017 Hualan Biological Bacterin completes a phase I trial in Influenza-A virus H7N9 subtype in China (NCT03196661)
- 06 Nov 2015 Phase-I clinical trials in Influenza-A virus H7N9 subtype (Prevention) in China (IM) (NCT03196661)